氨基末端 B型利钠肽前体检测临床研究进展(3)
[13]Seino Y, Ogawa A, Yanmashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evalution of heart failure[J]. Eur J Heart Fail, 2004,6: 295-300.[14] Duekel mann C, Mitter mayer F, Haider DG, et al. Asymmetridi methylarginine enhances cardiovascular risk prediction in patients with chronic heart failure[J]. Arterioscler Thromb Vasc Biol, 2007, 27: 1-7.
[15] Morita E ......
您现在查看是摘要页,全文长 1421 字符。